...13 GLP-1 RAs are FDA approved, with more currently in research and development. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....
...and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee. The meeting discussed two recently completed observational studies examining the risks of misuse, abuse, addiction, and...
...of Women in Workers' Compensation Stay Informed Healthesystems will keep you current on what’s happening in workers’ comp with: Workers’ Comprehensive Our e-newsletter covers the latest clinical developments, policy changes,...
...They are committed to providing us with the right information at the right time so we can make well educated and informed decisions about workers’ compensation patients.” - Client Partner...
...depression, major depressive disorder, and PTSD. It appears that state legislatures across the nation have taken these latest developments in earnest, as so far ten states have introduced bills to...
Healthesystems is transforming the workers' compensation pharmacy and ancillary benefits management experience. Powered by state-of-the-art technology Supported by human-centered service Informed by industry expertise Inspired by a commitment to care...
Intelligence That Informs Thoughtful Solutions The workers’ compensation industry is constantly evolving in response to economic, political, and cultural changes. As new challenges arise, we must come up with new...
...engagements MedMonitor An up-to-date timeline of FDA approvals that could impact workers' comp View All MedMonitor Information Social Hub Check out our latest posts and activity View All Social Media...
...nausea Imuldosa should not be used in patients with active infections, tuberculosis, malignancies, hypersensitivity, and noninfectious pneumonia. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp,...
...This comes after reports of serious heart problems and deaths from much higher than recommended doses of loperamide. These adverse events are due to loperamide's increased use as a drug...
...drugs that do not provide hallucinogenic effects – and possibly minimize more addictive elements. The new study tested if the psychedelic compound DOI (2,5-dimethoxy-4-iodoamphetamine) could reduce anxiety in mice by...
The California Division of Workers’ Compensation (DWC) adopted long-awaited Pharmaceutical Fee Schedule rules, introducing major changes to pharmaceutical billing and reimbursement. While there are many updates to the new rules,...
...in the workers’ compensation industry have become experts in managing this particular area of concern, these latest numbers remind us that opioid management continues to be more important than ever....
The California Division of Workers' Compensation (DWC) released its annual report on the Independent Medical Review (IMR) program, managed by Maximus Federal Services. IMRs resolve disputes over treatment denials or...
The National Council on Compensation Insurance (NCCI) released its latest Labor Market Insights report, offering a snapshot of current employment trends and their potential impact on workers’ compensation. By highlighting...
